Antimicrobial agents--mechanisms of action and clinical usage.
作者信息
Neu H C
出版信息
Curr Probl Surg. 1973 Jun:1-64.
PMID:4146368
Abstract
摘要
相似文献
1
Antimicrobial agents--mechanisms of action and clinical usage.
Curr Probl Surg. 1973 Jun:1-64.
2
[On the effect of hexetidine in vitro].[关于海克替啶的体外作用]
Arzneimittelforschung. 1969 Feb;19(2):164-7.
3
[Value of rifampicin in treatment of the patients with bronchopulmonary lesions. A clinical-bacteriological study].[利福平在支气管肺部病变患者治疗中的价值。一项临床细菌学研究]
Arzneimittelforschung. 1969 Aug;19(8):1283-5.
4
Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A beta-haemolytic streptococci in 2002-2003. Results of the multinational GRASP Surveillance Program.2002 - 2003年肺炎链球菌、流感嗜血杆菌、卡他莫拉菌及A组β溶血性链球菌的耐药性。多国GRASP监测项目的结果。
Int J Antimicrob Agents. 2005 Feb;25(2):148-56. doi: 10.1016/j.ijantimicag.2004.09.016.
5
[Antibiotic activity of the methacycline-triacetyl-oleandomycin association].
Antibiotica. 1966 Sep;4(3):169-89.
6
[Macrolide antibiotics: Streptococcus pneumoniae and Haemophilus influenzae].[大环内酯类抗生素：肺炎链球菌和流感嗜血杆菌]
Enferm Infecc Microbiol Clin. 1996 Oct;14(8):503-4.
7
Bacterial resistance to antimicrobials.
S Afr Med J. 1969 Jan 11;43(2):26-30.
8
Emerging patterns of microbial resistance.
Orthop Clin North Am. 1984 Jul;15(3):417-25.
9
[The extent of resistance on clinically important pathogens in the Federal Republic].[联邦共和国临床重要病原体的耐药程度]
Adv Clin Pharmacol. 1974;8:21-32.
10
[A call to attention: multiresistant bacteria and abuse of antibiotics].
Med Clin (Barc). 1985 Sep 28;85(9):364-7.
引用本文的文献
1
Infections caused by gram-negative pathogens: new clinical considerations.革兰氏阴性病原体引起的感染：新的临床考量
Bull N Y Acad Med. 1975 Oct;51(9):1075-83.
Zotero 插件